NSE ScannerHospitals & Diagnostics · Medical/Nursing Services · NSE: VIJAYA · data 2026-11-01
Vijaya Diagnostic Centre Ltd.
In plain words
Price: 9.3% below its 52-week high of ₹1,593.6.
Delivery: 56.2% of traded shares were kept for delivery over the last 10 sessions, against 47.3% over the last 60.
Latest results: a net profit of ₹53 cr for the quarter ended Jun 2026 (+38.5% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹857 cr |
| Net profit (last 12 months) | ₹187 cr |
| Sales growth, 3 years (yearly) | 21.0% |
| Profit growth, 3 years (yearly) | 26.9% |
At a glance
Promoters 52.5% (-0.1 pts in a year), pledged 2.0%, institutions 43.2%.
P/E 79.5, dividend yield 0.1%. Price relative to earnings and book value (low is cheaper, not better).
ROE 19.7%, ROCE 19.6%, operating margin 31.0%: how much profit it earns on the money it uses.
Debt/equity 0.44, Profit growth 26.9% and sales growth 21.0% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- High return on equity (19.7%).
- Healthy operating margin (31.0%).
- Profit grew 26.9% a year over 3 years.
- Promoters have pledged 2.0% of their shares.
- Expensive on earnings (P/E 79.5).
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
VIJAYA Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹230.98 crore, up 22.8% YoY and up 5.3% QoQ.
Net profit was ₹53.1 crore, up 38.5% YoY and up 10.8% QoQ.
Operating margin was 42.7% (39.1% a year ago).
EPS was ₹5.16, up 37.2% YoY and up 10.7% QoQ.
VIJAYA के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹230.98 करोड़; पिछले साल की तुलना में 22.8% की बढ़त, पिछली तिमाही की तुलना में 5.3% की बढ़त।
शुद्ध मुनाफ़ा: ₹53.1 करोड़; पिछले साल की तुलना में 38.5% की बढ़त, पिछली तिमाही की तुलना में 10.8% की बढ़त।
ऑपरेटिंग मार्जिन: 42.7% (एक साल पहले 39.1%)।
EPS: ₹5.16; पिछले साल की तुलना में 37.2% की बढ़त, पिछली तिमाही की तुलना में 10.7% की बढ़त।
VIJAYAના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹230.98 કરોડ; ગયા વર્ષની સરખામણીએ 22.8% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 5.3% વધારો.
ચોખ્ખો નફો: ₹53.1 કરોડ; ગયા વર્ષની સરખામણીએ 38.5% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 10.8% વધારો.
ઓપરેટિંગ માર્જિન: 42.7% (એક વર્ષ પહેલાં 39.1%).
EPS: ₹5.16; ગયા વર્ષની સરખામણીએ 37.2% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 10.7% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
28/100 · Neutral over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 14/30: Delivery 57.2% over the last 20 sessions vs 39.2% in the 40 before (1.46x); shares delivered per day 0.93x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 7/15: 5 schemes hold it, about ₹679 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 2/15: Verdict "None", sustained score 44/100.
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend ● Results ● Insider
- 16 Sept 26Dividend Dividend ₹2 (ex-date) +4.3% next session
- 6 Aug 26Results Q1 FY27 results: profit +38.5% YoY -2.8% next session
- 30 Jul 26Insider SAST disclosure: HDFC Mutual Fund acquired shares -2.0% next session
- 7 May 26Results Q4 FY26 results: profit +38.4% YoY +7.4% next session
- 13 Feb 26Results Q3 FY26 results: profit +22.8% YoY +1.4% next session
- 4 Nov 25Results Q2 FY26 results: profit +3.2% YoY -0.2% next session
- 29 Aug 25Dividend Dividend ₹2 (ex-date) +4.9% next session
- 28 Jul 25Results Q1 FY26 results: profit +22.3% YoY +4.6% next session
- 12 May 25Results Q4 FY25 results: profit +3.6% YoY -2.3% next session
- 12 Feb 25Results Q3 FY25 results: profit +36.0% YoY -11.6% next session
- 7 Nov 24Results Q2 FY25 results: profit +25.9% YoY +14.1% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹231 cr | ₹53 cr | +38.5% | 42.7% | 5.16 |
| Mar 2026 | ₹219 cr | ₹48 cr | +38.4% | 43.5% | 4.66 |
| Dec 2025 | ₹205 cr | ₹43 cr | +22.8% | 41.9% | 4.2 |
| Sept 2025 | ₹202 cr | ₹43 cr | +3.2% | 40.6% | 4.21 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 52.46% | 52.51% | 52.51% | 52.60% |
| Foreign institutions (FII) | 10.66% | 11.66% | 13.38% | 15.10% |
| Domestic institutions (DII) | 32.50% | 31.61% | 29.93% | 28.59% |
| Mutual funds | 31.44% | 30.66% | 29.06% | 27.98% |
| Retail investors | 3.55% | 3.49% | 3.47% | 3.14% |
| Number of shareholders | 70,966 | 67,251 | 62,946 | 57,784 |
Common questions
What was Vijaya Diagnostic Centre Ltd.'s latest quarterly profit?
Vijaya Diagnostic Centre Ltd. reported a net profit of ₹53 cr for the quarter ended Jun 2026 (+38.5% on the same quarter a year earlier), on revenue of ₹231 cr.
How much do promoters hold in Vijaya Diagnostic Centre Ltd.?
Promoters held 52.46% of Vijaya Diagnostic Centre Ltd. at the end of Sept 2026, with 1.96% of promoter shares pledged.
Is Vijaya Diagnostic Centre Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.44.
What is Vijaya Diagnostic Centre Ltd.'s P/E ratio?
About 79.5, based on the last 12 months' earnings and a price of ₹1,445.7 (data 2026-11-01).
What is the 52-week high and low of Vijaya Diagnostic Centre Ltd.?
The 52-week high is ₹1,593.6 and the 52-week low is ₹848.
Mutual funds holding Vijaya Diagnostic Centre Ltd.
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 5 schemes holding about ₹679 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| Nippon India Multi Cap Fund | Nippon India Mutual Fund | 0.78% | ₹419 cr |
| NIPPON INDIA PHARMA FUND | Nippon India Mutual Fund | 2.62% | ₹240 cr |
| ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND | Aditya Birla Sun Life Mutual Fund | 1.04% | ₹11 cr |
| Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF | Mirae Asset Mutual Fund | 0.83% | ₹8 cr |
| Mirae Asset Nifty 500 Healthcare ETF | Mirae Asset Mutual Fund | 0.52% | ₹0 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Ltd. | ₹1,445.7 | ₹14,906 cr | 79.5 | — | 19.7% | 19.6% | 0.44 | +43.3% |
| Dr. Lal PathLabs Limited | ₹1,906.4 | ₹31,997 cr | 58.9 | — | 21.6% | 25.3% | 0.08 | +23.7% |
| Dr. Agarwal's Health Care Ltd. | ₹509.2 | ₹16,116 cr | 109.5 | — | 6.8% | 9.1% | 0.53 | -1.4% |
| Metropolis Healthcare Ltd. | ₹545.65 | ₹11,309 cr | 56.2 | — | 13.4% | 16.3% | 0.15 | +12.3% |
| Thyrocare Technologies Ltd | ₹456.3 | ₹7,274 cr | 51 | 13.1 | 28.8% | 34.2% | 0.09 | +1.5% |
| Nephrocare Health Services Limited | ₹614.55 | ₹6,194 cr | — | — | 9% | 14.6% | 0.07 | +25.4% |
Compare VIJAYA with LALPATHLAB in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open VIJAYA in NSE Scanner →